Guangdong Marubi Biotechnology Co (603983) Valuation & Financial Model
Interactive Discounted Cash Flow (DCF) model for Guangdong Marubi Biotechnology Co (SSE:603983), currently being evaluated. In 2025, Guangdong Marubi Biotechnology Co generated $3.46 Billion in revenue and $68.63 Million in free cash flow. Explore projected intrinsic value assumptions based on institutional-grade macro metrics.
Valuation Methodology & Recent Performance
The financial model for Guangdong Marubi Biotechnology Co is calculated using an institutional discounted cash flow (DCF) engine utilizing recent operational metrics:
- Current Price: N/A
- Recent Revenue (2025): $3.46 Billion
- Free Cash Flow (2025): $68.63 Million
- Discount Rate (WACC): Derived using the Risk-Free Rate (e.g., 10Y Gov Bond) plus an Equity Risk Premium based on market volatility and stock price variance.
- Terminal Value: Projected using a perpetual growth model bounded by long-term macroeconomic estimates.